What's in Forma Therapeutics, Inc.'s pipeline?

Forma Therapeutics, Inc. has 5 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Forma Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Actavis Inc., Icahn School of Medicine at Mount Sinai, LEO Pharma, Novo Nordisk A/S, Padagis LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/forma-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Forma Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Forma Therapeutics, Inc. pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Etavopivat tablets	Etavopivat tablets	phase 3	Protein kinase C (PKC) activator	PKC (Protein Kinase C)	Hematology/Rare Blood Disorders
Etavopivat Tablets Low dose	Etavopivat Tablets Low dose	phase 3	KCNQ1 potassium channel activator	KCNQ1	Hematology/Oncology
Etavopivat Tablets High dose	Etavopivat Tablets High dose	phase 3	Nrf2 activator	Nrf2 (NFE2L2)	Hematology/Rare Blood Disorders

Therapeutic area mix

Hematology/Rare Blood Disorders · 2
Hematology/Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Icahn School of Medicine at Mount Sinai · 1 shared drug class
LEO Pharma · 1 shared drug class
Novo Nordisk A/S · 1 shared drug class
Padagis LLC · 1 shared drug class
Peplin · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Forma Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Forma Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/forma-therapeutics-inc. Accessed 2026-06-10.